Machine learning model, developed by researchers, has a relatively high prediction strength for clinical measures.
The severity of symptoms in posttraumatic stress disorder (PTSD) varies greatly across individuals in the first year after trauma and it remains difficult to predict whether someone might worsen, ...
Transcend Therapeutics’ Phase II IMPACT-1 study examining its neuroplastigen treatment for post-traumatic stress disorder ...
Transcend also saw significant improvements on secondary endpoints that assessed the rate of response, remission and loss of ...
The severity of symptoms in posttraumatic stress disorder (PTSD) varies greatly across individuals ... alterations happen in ...